Skip to content
Search

Latest Stories

North-East pharmacy group seeks buyers as it enters administration

A pharmacy group located in the North East is actively seeking a buyer in the wake of entering administration due to recent financial challenges.  Steven Ross and Allan Kelly, joint administrators from FRP Advisory, are spearheading the search for a buyer for the Gateshead-based group, including the holding companies for its eight pharmacies across North-East and Yorkshire – Northcare Ltd and Medway Ltd.

In recent months, the group encountered financial difficulties that have adversely affected both its businesses' cashflows and the group's capacity to manage its debts, according to the administrators.


The most recent financial reports for Northcare and Medway, spanning the year up to May 2022, indicated that the combined bank liabilities of the two firms exceeded £3.8 million.

Despite the financial struggles the businesses have undergone, no employee reductions have occurred to date. All shops within the group will maintain regular operations under the administrators' supervision during the buyer search.

"Pharmacies offer vital services to local communities, necessitating prompt action to commence administration and establish a protective framework that allows the eight sites across the group to continue their operations," commented Steven Ross, Partner and Joint Administrator at FRP Advisory.

The administrators have launched a marketing campaign to discover potential buyers for the group's shops, including Spinks the Chemist in Beverley and Gateshead, Norfolk Park Pharmacy in Sheffield, AD Phillips and Phillips Chemist in Trimdon, Wolsingham Pharmacy in Wolsingham, and Newham Pharmacy on the Hardwick Estate.

"We are committed to collaborating with suppliers, customers, and healthcare providers, including the NHS, to ensure uninterrupted service as we prepare for a sales process that secures the pharmacies' enduring future. We also encourage interested parties to come forward and register their interest," he added.

In July, two dozen parliamentarians urged the Prime Minister to take action due to the increasing wave of pharmacy closures in recent years. A letter signed by MPs and peers highlighted the risk of additional crises, pointing to the influence of growing business costs and consecutive years of funding cuts on pharmacy operations. Recent PSNC data shows that England has experienced the closure of over 639 local pharmacies since 2016, nearly averaging one closure per constituency."

Meanwhile, the Company Chemists’ Association recently revealed that a significant portion of distance selling pharmacies are breaching their NHS contracts. As per their recent study, 72 per cent of DSPs dispense over half of their prescriptions to patients in a single postcode area within a 10-mile radius of the pharmacy. The absence of effective regulation for these 'pseudo' distance selling pharmacies contributes to the closure of local pharmacies.

More For You

RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less